BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kochi T, Shimizu M, Ohno T, Baba A, Sumi T, Kubota M, Shirakami Y, Tsurumi H, Tanaka T, Moriwaki H. Preventive effects of the angiotensin-converting enzyme inhibitor, captopril, on the development of azoxymethane-induced colonic preneoplastic lesions in diabetic and hypertensive rats. Oncol Lett 2014;8:223-9. [PMID: 24959250 DOI: 10.3892/ol.2014.2136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Kato J, Shirakami Y, Yamaguchi K, Mizutani T, Ideta T, Nakamura H, Ninomiya S, Kubota M, Sakai H, Ibuka T, Tanaka T, Shimizu M. Allopurinol Suppresses Azoxymethane-Induced Colorectal Tumorigenesis in C57BL/KsJ-db/db Mice. GastrointestDisord 2020;2:385-96. [DOI: 10.3390/gidisord2040035] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Halici Z, Polat B, Cadirci E, Topcu A, Karakus E, Kose D, Albayrak A, Bayir Y. Inhibiting renin angiotensin system in rate limiting step by aliskiren as a new approach for preventing indomethacin induced gastric ulcers. Chemico-Biological Interactions 2016;258:266-75. [DOI: 10.1016/j.cbi.2016.09.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Miyazaki T, Shirakami Y, Mizutani T, Maruta A, Ideta T, Kubota M, Sakai H, Ibuka T, Genovese S, Fiorito S, Taddeo VA, Epifano F, Tanaka T, Shimizu M. Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis. Sci Rep 2021;11:492. [PMID: 33436792 DOI: 10.1038/s41598-020-79916-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shirakami Y, Ohnishi M, Sakai H, Tanaka T, Shimizu M. Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation. Int J Mol Sci 2017;18:E908. [PMID: 28445390 DOI: 10.3390/ijms18050908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
5 Shebl RI. Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity. Iran J Pharm Res 2019;18:1967-77. [PMID: 32184862 DOI: 10.22037/ijpr.2019.1100800] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Kochi T, Shimizu M, Sumi T, Kubota M, Shirakami Y, Tanaka T, Moriwaki H. Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice. BMC Gastroenterol 2014;14:212. [PMID: 25515685 DOI: 10.1186/s12876-014-0212-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
7 van der Laan JW, Buitenhuis WH, Wagenaar L, Soffers AE, van Someren EP, Krul CA, Woutersen RA. Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties. Front Med (Lausanne) 2016;3:45. [PMID: 27790617 DOI: 10.3389/fmed.2016.00045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
8 Li Y, Wang B, Zhang H, Wang Z, Zhu S, Ma H. High-level expression of angiotensin converting enzyme inhibitory peptide Tuna AI as tandem multimer in Escherichia coli BL21 (DE3). Process Biochemistry 2015;50:545-52. [DOI: 10.1016/j.procbio.2015.01.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
9 González N, Prieto I, Del Puerto-Nevado L, Portal-Nuñez S, Ardura JA, Corton M, Fernández-Fernández B, Aguilera O, Gomez-Guerrero C, Mas S, Moreno JA, Ruiz-Ortega M, Sanz AB, Sanchez-Niño MD, Rojo F, Vivanco F, Esbrit P, Ayuso C, Alvarez-Llamas G, Egido J, García-Foncillas J, Ortiz A; DiabetesCancerConnect Consortium. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget 2017;8:18456-85. [PMID: 28060743 DOI: 10.18632/oncotarget.14472] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
10 Fukuta K, Shirakami Y, Maruta A, Obara K, Iritani S, Nakamura N, Kochi T, Kubota M, Sakai H, Tanaka T, Shimizu M. Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice. Int J Mol Sci 2017;18:E413. [PMID: 28212276 DOI: 10.3390/ijms18020413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Horibe Y, Adachi S, Ohno T, Goto N, Okuno M, Iwama M, Yamauchi O, Kojima T, Saito K, Ibuka T, Yasuda I, Araki H, Moriwaki H, Shimizu M. Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study. Oncotarget 2017;8:97862-70. [PMID: 29228657 DOI: 10.18632/oncotarget.18416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]